OPRX say-on-pay proposal fails with 58.8% of votes cast against

OptimizeRx Corp

Say-on-pay: 4,722,546 for, 6,738,014 against, 393,696 abstain; broker non-votes 1,771,637.
Six directors elected; Gus D. Halas received 5,138,259 withheld votes, highest among nominees.
Ratification of UHY LLP as auditor passed: 13,611,868 for, 12,645 against, 1,380 abstain.
Board acknowledges vote and says it will evaluate compensation programs considering shareholder input.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

OptimizeRx Corp shareholders approved To ratify UHY LLP as the Company’s independent registered public accounting firm for the 2023 fiscal year at the 2023-06-07 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-06-07

Exact text from the filing

UHY LLP was ratified as the Company’s independent registered public accounting firm for the 2023 fiscal year based upon the following votes: Votes in Favor Votes Against Abstain 13,611,868 12,645 1,380

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

OptimizeRx Corp shareholders approved To elect six directors, each to serve for a term that expires at the next annual meeting of stockholders and until his or her successor has been elected and qualified or until his or her earlier death, resignation or removal at the 2023-06-07 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-06-07

Exact text from the filing

The following nominees were each elected to serve as director for a term that expires at the next annual meeting of stockholders and until his or her successor has been elected and qualified or until his or her earlier death, resignation or removal based upon the following votes: Nominee Votes For Votes Withheld Broker Non-Votes William J. Febbo 10,694,810 1,159,446 1,771,637 Gus D. Halas 6,715,997 5,138,259 1,771,637 Lynn O’Connor Vos 7,402,326 4,451,930 1,771,637 James Lang 7,097,971 4,756,285 1,771,637 Patrick Spangler 8,072,200 3,782,056 1,771,637 Gregory D. Wasson 8,073,940 3,780,316 1,771,637

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

OptimizeRx Corp shareholders rejected To approve, on an advisory basis, the compensation of the Company’s named executive officers (the "say on pay proposal") at the 2023-06-07 meeting.

Proposal: say on pay
Outcome: failed
Meeting: 2023-06-07

Exact text from the filing

The say on pay proposal was not approved based upon the following votes: Votes in Favor Votes Against Abstain Broker Non-Votes 4,722,546 6,738,014 393,696 1,771,637

View on SEC.gov

560 shareholder votes filed in the last 30 days. Browse all shareholder votes →

OptimizeRx Corp filing history →

Source: SEC EDGAR

accession 0001213900-23-047179

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.